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Abstract: Hydatidiform mole is an abnormal human pregnancy
characterized by the fetus being absent or nonviable, and the chorionic
villi being vesicular and with trophoblastic hyperplasia. Most often, the
mole phenotype is seen in conceptuses with an excess of paternally
inherited genome set(s) relative to maternally inherited genome set(s),
suggesting that the phenotype is caused by an excess of genome with a
paternal imprinting pattern. However, it is unknown if correct parental
origin of every imprinted gene is crucial for normal early differentiation
or if abnormal parental imprinting of only one, or some, gene(s) can
cause the mole phenotype.
Two conceptuses included in the DanishMole Project stood out since
they presented with vesicular chorionic villi and without signs of fetal
differentiation, and had apparently biparental diploid genomes, and no
mutations in NLRP7 or KHDC3L were detected in the mothers. These
conceptuses were subjected to a centralized histopathological revision
and their genetic complements were scrutinized using fluorescence in
situ hybridization, and DNA-marker and array comparative genomic
hybridization analyses. Both conceptuses showed dysmorphic chorionic
villi with some similarities to hydatidiform moles; however, no definite
florid trophoblast hyperplasia was observed. Both conceptuses showed
paternal hemizygosity of 11pter-11p15.4, most likely in nonmosaic state.
Our findings suggest that the product of one (or a few) maternallyigil Kjeldsen, MD ndreasen, PhD,
ars Bolund, MD, MedDr, and Mette Nyegaard, PhD
parental imprinting of genes in other regions contribute to the phenotype
of a hydatidiform mole.
(Medicine 94(44):e1776)
Abbreviations: Array CGH = array comparative genomic
hybridization, BWS = Beckwith–Wiedemann syndrome, FISH =
fluorescence in situ hybridization, HM = hydatidiform mole, PM =
paternal–maternal, PMD = placental mesenchymal dysplasia, PP =
paternal–paternal, PPM = paternal–paternal–maternal, SNP =
single-nucleotide polymorphism, UPD = uniparental disomy.
INTRODUCTION
H ydatidiform mole (HM) is an abnormal human pregnancy,characterized by vesicular swelling of the chorionic villi
and hyperplasia of the trophoblastic layer. Most HMs are either
diploid androgenetic (paternal–paternal [PP]), or triploid, with
two chromosome sets originating from the father and one from
the mother (paternal–paternal–maternal [PPM]). However, rare
diploid HMs with biparental genomic markers (paternal–
maternal [PM]) have been reported.1–6 Some of these rare
conceptuses seem to have a paternal epigenotype on the
maternal allele of one or more imprinted genes, due to mutation
in both alleles of NLRP7 or KHDC3L in the mother.7–10 In other
cases, diploid moles with biparental genetic markers are
mosaics, one cell line being diploid androgenetic and the other
diploid biparental (PP/PM).11–13 PP/PM mosaicism is often
associated with placental mesenchymal dysplasia (PMD), where
the placenta may be enlarged and cystic, but without tropho-
blastic hyperplasia.14–16 Due to the morphologic similarities
between HM and PMD, the latter has also been named "pseudo-
partial mole".17 In PP/PM mosaics, the abnormal phenotype is
likely to be caused by the androgenetic cell line. Thus, it seems
that a mole/a mole-like phenotype is seen in conceptuses with an
excess of genome with a paternal imprinting pattern, relative to
genome with maternal imprinting pattern.
However, it is possible that the correct imprinting pattern
of every imprinted gene is not crucial for normal early differ-
entiation, and a molar or mole-like phenotype may be caused by
abnormal imprinting pattern of only one, or some, genes. No
such genes have yet been identified, although some well defined
syndromes in liveborn individuals are caused by abnormalities
restricted to one or a few imprinted genes. For instance, with-
Wiedemann syndrome (BWS), in which the placenta often
display PMD,18 is most often related to reduced function of
one, or more, maternally expressed genes in 11p15.5.19
Since 1986, we have collected samples in the Danish Mole
Project from placentas suspected of being HMs, because ofi visible to the naked eye. On histological
have been classified as HMs, whereas
erto been classified as PMD.20
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TABLE 1. Two cases of conceptuses with paternal hemizygosity of 11p15.4-pter: Family and fertility histories, clinical presen-
tation, and morphological observations
Case 101 Case 635
Family and fertility history, apart
from present pregnancy
The parents had 3 children, 4 miscarriages,
and 1 stillbirth wk 30 with a very small
fetus. See pedigree (Figure 1).
The parents had 1 child and no miscarriages.
Family history inconspicuous.
Ultrasound ULS week 15þ 6, due to previous
miscarriages: ‘‘Gestation sac 3 cm.
Scattered echoes. No fetus.’’
Routine ULS week 12: ‘‘Suspicion of mole,
complete HM or partial HM’’
Termination Week 16þ 1 (1986) Week 13þ 1 (2001)
Se-hCG at diagnosis (time to
se-hCG undetectable)
Not measured (19 days) 6379 IU/mL (35 days)
Macroscopic inspection of unfixed
evacuated tissue
Gynaecologist: ‘‘Very suspect of mole. No
fetal parts’’
Gynaecologist: ‘‘Mole. No fetal parts’’
Sample forwarded for Danish Mole Project:
Vesicles 4 mm
Sample forwarded for Danish Mole Project:
Vesicles 0.5–5mm
Local histopathologist Partial HM/non-HM? Complete HM
Hydropic villi without vessels. Some fjords.
No distinct trophoblastic hyperplasia. No
nucleated RBC
Large, round, edematous villi. Some cisterns,
some trophoblast inclusions. No fjords. Slight
trophoblastic hyperplasia, multifocally
circumferential. Villous vessels without
nucleated RBC
Histopathological review 2003 Partial (complete?) HM Partial HM
Small edematous/vesicular villi. Focal, slight
trophoblastic hyperplasia. Few
invaginations. No nuclear debris. No fetal
parts
Small edematous/vesicular villi
Almost no trophoblastic hyperplasia. Few
invaginations. No nuclear debris. No fetal parts
Centralized histopathological
review 2014
Nonmolar conception Nonmolar conception
Focally hydropic and scattered irregular
dentate villi
Hydropic villi with few cisterns
Trophoblastic inclusions Scattered dentate villi and inclusions
Some circumferential trophoblastic sprouts,
but no definite florid abnormal trophoblast
hyperplasia
Occasional empty vessels
Some circumferential trophoblastic sprouts, but
no definite florid abnormal trophoblast
scan
Sunde et al Medicine  Volume 94, Number 44, November 2015We here report the presence of a deletion on the maternal
chromosome 11 affecting the region 11pter-11p15.4 in two
unrelated diploid biparental conceptuses without a fetus and
with dysmorphic chorionic villi with some phenotypic sim-
HM¼ hydatidiform mole, RBC¼ red blood cells, ULS¼ ultrasoundilarities to HMs. This raises the possibility that one (or a few)
gene(s) crucial for normal early embryonic differentiation is
located within this region.
MATERIALS AND METHODS
In the Danish Mole Project, unfixed samples from con-
ceptuses presenting with vesicular villi on ultrasound or by visual
inspection of aborted tissue, are collected consecutively. At the
genetic laboratory, the samples are inspected macroscopically,
and only samples with at least 10 vesicular chorionic villi, with
diameters >1 mm, are included. In the period April 1986 to June
2003, samples from 270 conceptuses were received and classi-
fied as HMs by a centralized histopathologic review.20
2 | www.md-journal.comOf the 270 conceptuses, 162 were diploid. In 1 of the
diploid conceptuses, the parental origin could not be deter-
mined. 150 cases were androgenetic (PP), including 1 case
(case 497), which, in the original study, was erroneously
classified as diploid biparental due to contamination with
maternal DNA (data not shown),20 and 8 cases that were part
of multiple pregnancies comprising one or two normal preg-
nancies and a diploid androgenetic HM.21 In the remaining 11
diploid cases, genetic markers from both parents were demon-
strated; none of these cases were part of a multiple pregnancy.
However, 8 were mosaics with two cell lines, one androgenetic
and one biparental (PP/PM). In the last 3 of these 11 cases, one
biparental (PM) cell line, only, was identified.12 One of these
3 cases (case 131) was part of an extensively studied family
in which the mother carries mutations in both alleles of
hyperplasia
ning.NLRP7.5,22–24
The remaining two diploid cases with one biparental cell
line (cases 101 and 635) seemed "unexplained", with no
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
mutations detected inNLRP7 orKDHC3L.24 Details about these
two cases are given in Table 1.
Clinical data were obtained from a questionnaire filled in
by the parents of the conceptuses, and from the histopatholo-
gical and medical records.
Data on the morphology were retrieved from the original
pathology reports made by the local pathologists, and from the
centralised review performed previously ("review 2003").20 A
renewed centralized revision was made by three of us (HL, AG,
and NS). Histopathological evaluation was performed on hema-
toxylin and eosin-stained sections. Immunohistochemical stain-
ings were performed on representative formalin-fixed paraffin-
embedded tissue sections using a mouse monoclonal antibody
directed against the p57KIP2 protein, (clone 25B2 at 1:100;
Novocastra). The presence of distinct nuclear staining was
evaluated in the villous stromal cells and the cytotrophoblasts.
Ploidy was determined by karyotyping of uncultured and/
or cultured cells, and/or by measurement of the nuclear DNA
contents by flow cytometry of unfixed nuclei, using chicken and
trout erythrocytes (that both are nucleated and in diploid state
have quantities of DNA per nucleus that are different from the
quantity of DNA in a human diploid cell) as controls (DNA-
ploidy).25
DNAwas prepared from parental leukocytes using standard
Medicine  Volume 94, Number 44, November 2015techniques. DNA from conceptuses was prepared by digesting
unfixed vesicular villi in lysis buffer (tris(hydroxymethyl)ami-
nomethane hydrochloride 10 mM, ethylenediaminetetraacetic
FIGURE 1. Pedigree of the family of case 101. Case 101 (III:5) that
included in the Danish Mole Project as vesicular chorionic villi were
miscarriages of II:2 and III:1 was available. IV:2 has the karyotype 46,X
delay and mild dysmorphic features. IV:4 has a normal karyotype.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.acid 1 mM, NaCl 150 mM, sodium dodecyl sulfate 0.5%, pH
10.5) containing proteinase K (1 mg/mL) for 2 hours at 568C.
DNA was subsequently extracted with phenol and chloroform,
precipitated with sodium acetate and ethanol, and resuspended.
Analysis of the parental origin of the genome of the conceptuses
using a multiplexed analysis of 16 microsatellite markers
(AmpFlSTR) was performed according to the manufacturer’s
guidelines. 10 ng template DNA was used.
Global DNA array analysis was carried out using the
Genome-Wide Human SNP Array 6.0 (SNP6) (Affymetrix,
Santa Clara, CA). In brief, 500 ng genomic DNAwas hybridized
to the array using the Human mapping SNP6.0 assay kit and
following the manufacturer’s protocol. Staining and washing of
the arrays were carried out on a Fluidics Station 450 (Affyme-
trix) and the arrays were then scanned with a GeneChip scanner
3000 7G system (Affymetrix). Genotyping was performed with
the Geno-typing Console V4.1 software (Affymetrix) using the
Birdseed V2 algorithm, including an extra 30 reference samples
to improve the accuracy of genotype calls. Genotyping call rate
were above 98.5% for all samples. The copy number analysis
was performed using the SNP6 array data and the software
Partek Genomics Suite (MO) V6.11 using the copy number
baseline files generated from 270 SNP6 HapMap samples
distributed by Partek. All files and genomic positions are from
Paternal Hemizygosity in 11p15 in Molesthe hg19 version of the human genome. Genotypes from 640
SNPs from the 3.5 Mb 11pter-11p15.4 region were extracted in
Genotyping Console identifying the parental origin of the
had the karyotype 46,XY,der(11)t(11;21)(p15.4;q22.3)mat was
observed. No information about the morphology of the other
Y,der(21)t(11;21)(p15.4;q22.3)mat and has mild developmental
www.md-journal.com | 3
Details on the fertility and the family histories of thedeleted region in each of the two cases using the SNPTrio
workflow in Partek. After filtering all non-informative SNPs in
each trio, 40 informative SNPs remained in the 101 trio and 32
informative SNPs remained in the 635 trio in the region
of interest.
Structural chromosome abnormalities were explored using
fluorescence in situ hybridization (FISH) with probes specific
for the centromeres and telomeric regions of the short arms of
Sunde et alchromosomes 11 and 12.
The regional Committee on Biomedical Research Ethics
approved the study. All participants gave informed consent.
RESULTS
Two independent miscarriages - case 101 and case 635 -
were included in the Danish Mole Project, because vesicular
chorionic villi were observed. In both cases, previous histo-
pathologic examinations had classified the conceptuses as HMs,
and in both cases we identified biparental diploidy and an
FIGURE 2. Photomicrographs of the two pregnancy products with mo
101 showing focal hydrops and a few well formed cisterns () and in
inclusions (!). In both cases, there was no definite trophoblastic hype
negative in both cytotrophoblasts and villous stromal cells. Maternal
controls. Original magnifications: x25 for photos and 100 for insets
4 | www.md-journal.comunbalanced translocation causing paternal hemizygosity in
chromosome 11pter-11p15.4.
Medicine  Volume 94, Number 44, November 2015parents, the clinical presentations, and the morphologic obser-
vations are given in Table 1 and Figure 1.
Centralized Histopathological Review, 2014
At a renewed centralized revision, both pregnancy pro-
ducts showed morphologically abnormal, dysmorphic, chorio-
nic villi with scattered dentate villi and inclusions. Hydropic
changes and/or few well formed cisterns were seen as well.
Empty vessels were noted, but no nucleated fetal red cells.
There was no definite florid abnormal trophoblast hyperplasia
(Fig. 2). In both cases, immunohistochemical analyses of
p57KIP2, which, in cytotrophoblasts and villous stromal cells,
is normally expressed from the maternal allele of the gene
CDKN1C located in 11p15.5, were negative in these cells.
Although some of the observed features are seen in HMs,
rphologically abnormal chorionic villi (cases 101 and 635). A, Case
clusions (!). B, Case 635 showing scattered dentate villi () with
rplasia, and immunohistochemical staining for p57KIP2 (insets) was
decidua and intermediate trophoblast served as positive internal
.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.






Number Analysis FISH Conclusion
Case 101
Conceptus Diploidyy TH01: 173z Del(11)(pter-3.3Mb) NA 46,XY,der(11)t(11;21)
Dup(21)(45.5 Mb-qter) (p15.4;q22.3)mat
Mother 46,XX TH01: 177/185 Normal t(11;21) 46,XX,t(11;21)
Father 46,XY TH01: 173/187 Normal 46,XY
Case 635
Conceptus 46,XY TH01: 177 Del(11) (pter-3.5 Mb) 46,XY,der(11)t(11;12)
vWA: 176/180/180 Del(11) (pter-3.5 Mb) (p15.4;p13.31)mat
Mother 46,XX TH01:173/185 Normal Normal 46,XX
vWA: 180
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Only results indicating deviation from diploid, biparental genome ar
contents.zFurther the alleles observed in the Amelogenin locus indicatethe lack of definitely abnormal trophoblast proliferation pre-
In none of the two conceptuses did we observe signs ofcluded the diagnosis HM. As the few vessels noted were
inconspicuous, there was no suspicion of PMD.
Genetic Analyses
Table 2 summarizes the results of the genetic analyses. In
both conceptuses, analyses of ploidy and parental origin of the
genome suggested diploidy, with a normal biparental origin of
the genome. However, analyses of 16 microsatellite markers
(AmpFlSTR) indicated that there were not balanced biparental
contributions to all parts of the genome: In both cases, there was
no maternal allele for the locus THO1 (11p.15.5), and in case
635, an exceptionally high peak representing the maternal allele
was observed for the locus vWA (12p13.32).
Genome-wide SNP6 analysis of case 101 confirmed the
deletion on the maternally inherited chromosome 11 (Fig. 3).
The breakpoint was mapped to cytoband 11p15.4, close to the
border to 11p15.5, at genomic position 3.3 Mb (hg19) (between
MRGPRE and ZNF195). In addition, a maternal gain was
identified at chromosome 21q22.3-qter, with a breakpoint at
genome position 45.5 Mb (hg19), suggesting that this conceptus
had a maternal derivative chromosome 11, resulting from a
translocation between 11p15.4 and 21q22.3.
In case 635, the predicted deletion on the maternal chromo-
some 11 and the gain of maternal chromosome 12 were also
confirmed by SNP analysis. The breakpoints were mapped to
cytoband 11p15.4 at genome positions 3.5 Mb (hg 19) (between
ZNF195 and ART5), and at cytoband 12p13.31 at genome
position 8.4 Mb (hg19) (between FAM90A1 and
LOC389634), respectively. For both conceptuses, the paternal
hemizygosity in 11p15 was confirmed using all informative
SNPs in the region. In the two cases, the breakpoints on
chromosome 11p15 were remarkably similar, but not identical,
with the deletion in case 101 being the smallest. The minimal
chromosome region deleted in both conceptuses encompasses
105 genes including at least 11 genes that are subject to genomic
imprinting (See Table, Supplemental Digital Content 1, http://
links.lww.com/MD/A478).
In the mother of case 101, FISH with probes specific for
the centromere and p-telomere of chromosome 11 confirmed a
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.reciprocal translocation between chromosomes 11 and 21. FISH
with probes for the centromeres and the p-telomeres of chromo-
somes 11 and 12 disclosed no cytogenetic abnormalities in the
parents of case 635 (Fig. 4).
cence in situ hybridisation, SNP¼ single-nucleotide polymorphism.
ven.yDetermined by flow cytometric quantification of the nuclear DNA
e presence of both X and Y chromosomes.mosaicism, neither by analyses of microsatellite markers nor in
the SNP analysis.
DISCUSSION
A HM is a conceptus defined by its phenotype hallmarked
by vesicular swelling of the chorionic villi and trophoblastic
hyperplasia.26,27 In 1991, Moscoso suggested the name PMD
for the phenotype of a placenta with hyperplasia and edematous/
cystic changes of the stem villi, dilated vessel on the fetal
surface of the placenta, and no trophoblastic hyperplasia.14
Most HMs seem to be diploid androgenetic (PP) or triploid,
with an extra chromosome set from the father (PPM), whereas
tetraploid HMs, aneuploid HMs, and diploid biparental HMs
caused by deficient imprinting are rare.28 However, both in
placentas classified as HMs and in placentas classified as PMD,
mosaicism for two diploid cell lines - one androgenetic and one
biparental (PP/PM) - have been observed.11–13,15,16
In the present study, we performed whole genome analysis
of DNA markers in two diploid conceptuses with no fetus and
villous dysmorphism reminiscent of HM, and found paternal
hemizygosity for overlapping regions in 11pter-11p15.4. These
cases fulfilled the initial inclusion criteria of the Danish Mole
Project, as macroscopically visible vesicular chorionic villi
were observed; and at previous histopathological examinations,
these were classified as HMs. Review by specialist pathologists
independently classified the villous morphology of these con-
ceptuses as dysmorphic, but likely nonmolar, concordant with
low and rapidly declining maternal serum-human chorionic
gonadotropin (hCG) values. There were no findings suggestive
of PMD.
We cannot exclude that haploinsufficiency for genes in
the deleted region on chromosome 11 influenced the
phenotype. Further, as one of these conceptuses harbored an
extra maternal copy of a segment of chromosome 21 and the
other had an extra maternal copy of a segment of chromosome
www.md-journal.com | 5
FIGURE 3. Results of SNP6 analyses. Genomic profiles of two cases determined by SNP array. A, Case 101: deletion of 11pter-11p15.4,
gain of 21q22.3-qter; case 635: deletion of 11pter-11p15.4, gain of 12pter-12p13.31. B, Zoom in on the breakpoints on chromosome 11.
Red bars: probes showing deletion; blue bars: probes showing normal copy number. Note that the deletion in case 635 was slightly larger
than in case 101, including one additional gene (ZNF195). SNP¼ single-nucleotide polymorphism.
Sunde et al Medicine  Volume 94, Number 44, November 2015
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FIGURE 4. FISH in families 101 and 635. A, Metaphase from the mother of case 101; probes specific for the centromere (red) and p-




Medicine  Volume 94, Number 44, November 2015 Paternal Hemizygosity in 11p15 in Moles12, we cannot exclude that trisomy for sequences on
chromosome 12 or 21 also contributed to the phenotype.
from the mother and father of case 635; probes specific for the cen
normal chromosomes 11. D and E, Metaphases from themother an
telomere (red) of chromosome 12 identifying normal chromosomHowever, as the phenotype in the two cases had similarities
to the phenotype ofHMs that is correlated to a relative excess of
the paternal genome, and as the excess maternal contribution to
FIGURE 5. Model of genes possibly involved in themolar phenotype. S
observations in cases 101 and 635 indicate that absence of the produc
vesicular chorionic villi. In mosaic PP/PM conceptuses suspected of HM
cells having an androgenetic genome, PP) and p57KIP2-positive cy
genome, PM) in conceptuses without trophoblastic hyperplasia; where
cells and the cytotrophoblasts were p57KIP2-negative (ie, androgenetic
one or more gene(s) in 11pter-11p15.4 in stromal cells can cause accu
may be influenced by absent maternal expression in cytotrophoblast
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.the genomic affected different regions in the two conceptuses,
it is likely that the absence of a fetus and the placental
mere (red) and p-telomere (green) of chromosome 11 identifying
ther of case 635; probes specific for the centromere (green) and p-
12. FISH¼fluorescence in situ hybridization.dysmorphism in these two cases were caused by deficiency
of the product of one (or more) maternally expressed gene(s)
in 11p15.
chematic representation of a cross-section of a chorionic villus. The
t from maternally expressed gene(s) in 11pter-11p15.4 can cause
, Lewis et al observed p57KIP2-negative stromal cells (ie, stromal
totrophoblasts (ie, cytotrophoblasts having a normal biparental
as in conceptuses with trophoblastic hyperplasia, both the stromal
, PP).19 Thus, it is possible that absence of maternal expression of
mulation of fluid in the villi, whereas the trophoblastic hyperplasia
s of genes outside this region.
www.md-journal.com | 7
Imprinting errors in 11p15 are implicated in BWS. In
approximately 20% of patients with BWS, the syndrome is
ascribed to paternal uniparental disomy (UPD) of the entire
chromosome 11, or to a part of the chromosome including
11p15.5 (UPD11pat).29 Importantly, in all cases published, the
abnormality was present in a mosaic state, and the severity of
the phenotype in mosaic UPD11pat seems to correlate with the
frequency of the cells with UPD.30,31 PMD has repeatedly been
observed in the placenta of fetuses with BWS, and this placental
phenotype may be especially frequent among those cases
caused by mosaicism for UPD11pat.32 A case of a conceptus
surviving to gestational week 34, with PMD and fetal over-
growth, showed mosaicism for paternal hemizygosity of
11p15.5. This case also suggests that loss of maternal
11p15.5 might be associated with PMD.29
Nonmosaic deletion of 11p15.5 seems to be unreported in
liveborn individuals.33 Further, by October 2014, no such case
were registered in Decipher34 or in Danish Cytogenetic Central
Registry that holds data on all cytogenetic analyses performed
for clinical reasons in Denmark (Jan Hansen, personal com-
munication).
The present two cases of paternal hemizygosity for 11pter-
11p15.4 most likely were nonmosaic: in both cases, no sign of a
normal cell line was noted in the genetic analyses, and further-
more, in one case, the deleted chromosome was inherited. As no
fetal differentiation was observed, it seems likely that the
product of one (or a few) maternally expressed gene(s) on
the tip of chromosome 11 is necessary for early embryonic
differentiation to take place, as already suggested by others.19
These may include genes expressing transcripts directly trans-
lated into essential proteins, or transcript repressing paternal
transcription, the deletion thereby indirectly causing an over-
expression of genes from the paternally inherited genome.
As the two present cases did not show trophoblastic
hyperplasia, our findings also indicate that loss of maternally
expressed gene(s) in 11pter-11p15.4, only, is not sufficient for
all the features of the molar phenotype to evolve. Possibly
abnormal parental (paternal) origin or abnormal imprinting in a
number of loci may contribute to a more or less pronounced
molar phenotype ("polyepigenetic" etiology). Interestingly, in
mosaic PP/PM conceptuses with some suspicion of HM and no
trophoblastic hyperplasia, Lewis et al13 observed p57KIP2-
positive cytotrophoblasts and p57KIP2-negative stromal cells,
whereas in the cases with trophoblastic hyperplasia, also the
cytotrophoblasts were p57KIP2-negative. Thus, it is possible that
absence of maternal expression of one or more gene(s) in
11pter-11p15.4 in stromal cells can cause a vesicular appear-
ance of the villi, whereas trophoblastic hyperplasia may be
caused by absence of maternal expression of one or more
gene(s) outside this region in the cytotrophoblasts (Fig. 5).
Such a mechanism may also explain the seemingly conflicting
observations previously reported in HMs, showing aneuploidy
for chromosome 11: two diploid androgenetic conceptuses,
trisomic due to a retained maternal chromosome 11 had the
phenotype of complete HM,35,36 and a triploid diandric mole
that was paternal disomic for chromosome 11 also showed the
phenotype of complete HM.37 Furthermore, this mechanism
may explain some of the inconsistencies between classification
of HMs using morphologic criteria and the classification using
genetic criteria.20
Immunostaining of p57KIP2, encoded by the gene CDKN1C
Sunde et allocalized in 11p15.5, has been shown to be a method for
discrimination of complete and partial HMs with high sensitivity
and specificity. Rare misclassifications have been attributed to
8 | www.md-journal.comaneuploidy for maternal chromosome 11 in HMs, with two
paternal chromosome sets or mosaicism PP/PM.38 The obser-
vation of a borderline molar villous morphology in the present
two conceptuses with paternal hemizygosity for 11p15.5 illus-
trates another reason why inspection of the morphology of
aborted tissue by a skilled histopathologist cannot be replaced
by a simple scoring of tissue immunostained for p57KIP2.
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